Example: Heart Attack

Search clinical trials for: Adrenergic alpha-2 Receptor Antagonists

Total 257 results

NCT00040209

Completed

JP-1730 to Treat Parkinson's Disease

Conditions: Parkinson Disease
NCT01031979

Completed

Prolonged Exposure for Post Traumatic Stress Disorder (PTSD) With/Without Yohimbine

Conditions: Post-Traumatic Stress Disorder
NCT04638660

Recruiting

Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) in Subjects With Dim Light Vision Disturbances

Conditions: Dim Light Vision Disturbances
NCT04620213

Active, not recruiting

Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) to Reverse Pharmacologically-Induced Mydriasis

Conditions: Mydriasis; Dilation
NCT04024891

Completed

Safety and Efficacy of Ophthalmic Phentolamine Mesylate to Reverse Pharmacologically Induced Mydriasis

Conditions: Mydriasis; Dilation
NCT01703559

Completed

The Safety and Efficacy of Phentolamine Mesylate Ophthalmic Solution in Subjects With Severe Night Vision Disturbances

Conditions: Night Vision Complaints; Decrease in Night Vision; Disturbance; Vision, Loss
NCT04675151

Not yet recruiting

Safety and Efficacy of Nyxol With Pilocarpine Eye Drops in Subjects With Presbyopia

Conditions: Presbyopia
NCT03520543

Completed

[11C]Yohimbine PET Study of alpha2-AR

Conditions: Healthy Controls
NCT00814047

Completed

The Effect of an α2-Adrenoceptor Antagonist (Yohimbine) on Dynamic Autoregulation in the Human Middle Cerebral Artery and Ophthalmic Artery

Conditions: Blood Flow Velocity; Autoregulation; Ocular Physiology
NCT00029627

Completed

Brain Receptors in Sympathetic Nervous System Regulation

Conditions: Healthy
NCT04346394

Not yet recruiting

The Role of the Noradrenergic System in the Nonmotor Symptoms of Parkinson's Disease

Conditions: Parkinson Disease
NCT02874820

Terminated

I2PETPG - Imidazoline2 Binding Sites in a Group of Participants Diagnosed With AD

Conditions: Alzheimer Disease
NCT02323217

Completed

I2PETHV - Imidazoline2 Binding Site in Healthy Volunteers

Conditions: Healthy Volunteers; Alzheimer Disease; Molecular Imaging
NCT00042536

Completed

Effects of Yohimbine and Naltrexone on Sexual Function

Conditions: Erectile Dysfunction
NCT03219008

Unknown status

Multi-Dimensional Diagnosis,Individualized Therapy,and Management Technique for Major Depressive Disorder:Based on Clinical and Pathological Characteristics

Conditions: Depressive Disorder
NCT00294944

Withdrawn

The Effectiveness of Idazoxan in Treating TRD

Conditions: Major Depressive Disorder
NCT03679052

Completed

Prophylactic Mirtazapine or Clonidine for Post-spinal Anesthesia Shivering

Conditions: Shivering
NCT04432688

Recruiting

The Safety and Effectiveness of Latuda® Post-marketing Surveillance in the Treatment of Chinese Schizophrenia Patients

Conditions: Schizophrenia
NCT04383691

Not yet recruiting

A Study of Lurasidone Compared With Placebo for the Treatment of Bipolar I Depression

Conditions: Bipolar I Depression
NCT04614584

Not yet recruiting

Mirtazapine and Methamphetamine Drug-drug Interaction Study

Conditions: Methamphetamine Use Disorder; Drug Interaction; Cardiovascular Abnormalities
NCT04547842

Recruiting

Mirtazapine Versus Dexamethasone in Preventing Postoperative Nausea and Vomiting

Conditions: Post Operative Nausea and Vomiting
NCT04359147

Recruiting

The Role of Stress Neuromodulators in Decision Making Under Risk and Selective Attention to Threat

Conditions: Yohimbine; Hydrocortisone; Yohimbine + Hydrocortisone; Placebo
NCT04446039

Not yet recruiting

Non-interventional, Retrospective Cohort Study to Explore Antidepressant Treatment in Korea

Conditions: Major Depression
NCT04231708

Not yet recruiting

Effects of Pharmacological Stress and rTMS on Executive Function in Opioid Use Disorder

Conditions: Opioid Use Disorder
NCT04312503

Recruiting

Observational Study on the Effect of Switch to Lurasidone in Subjects With Schizophrenia"

Conditions: Schizophrenia